Home > Industry > Automotive

Industry 01 · Top Vertical

Pharma DTC

For regulated direct-to-consumer healthcare brands

In pharma, the goal is not just reach. It is education, condition relevance, patient action, and measurable prescription movement — all within FDA, MLR, and privacy constraints.

Already Convinced? - Build Your CTV Growth Plan →

Home > Industry > Automotive

Industry 01 · Top Vertical

PHARMA DTC · REGULATED

Pharma DTC

For regulated prescription brands, telehealth, and supplements

Pharma DTC is a regulated, condition-driven category. CTV should build condition awareness and treatment consideration within fair-balance rules — then prove whether exposure drives patient sign-ups, telehealth consults, and cost per acquired patient.

WHERE IT USUALLY BREAKS

Why Pharma DTC CTV Underperforms

Regulated brands measure CTV against script-level metrics — new-to-brand prescriptions, total prescriptions, persistence — that live in third-party claims data and can’t be read inside a media platform, so the campaign gets judged on a number the media buy was never instrumented to move. The measurable in-platform outcomes — sign-ups, consults, purchases — get ignored, and the buy drifts.

Two things we find almost every time. First, the audience is built on third-party segments tagged with specific diagnosis codes rather than contextual or de-identified condition targeting — the exact online-tracking practice the FTC and HHS Office for Civil Rights warned health and telehealth providers about in their July 2023 joint letter. Second, the major statement and ISI never make it into the CTV cut, so fair balance fails, and the conversion pixel is set to log condition-tied events against an identifiable household it shouldn’t be logging at all.

Already Convinced? - Build Your CTV Growth Plan →

CORE CONVICTIONS.

Industry 01 · Top Vertical

THE MEASUREMENT FRAMEWORK

The Four Questions Your Board Will Ask

CTV’s job in pharma DTC is to move a condition-relevant audience toward talking to a doctor or starting a program, inside fair-balance rules; these four questions test whether it did and what each patient action cost.

Your KPIs get set together on the call, against your numbers — not this list.

Already Convinced? - Build Your CTV Growth Plan →

01

Did the right household notice?

Brand Signals - measured against a GEO CONTROL

Households reached (contextual / de-identified condition audiences)

Frequency per household

Completed views / view-through rate on the fair-balance spot

Reached vs. Recalled

Recall by market

02

Did it change what they did next?

Intent Signals - behavior after exposure

Condition and treatment page sessions

Prescribing-information / ISI page views

“Find a doctor” or doctor-discussion-guide pixel event

Symptom-checker sessions

Telehealth visit-start pixel event

03

Did it move the business?

BUSINESS OUTCOMES MEASURED AGAINST A HOLDOUT

Patient sign-ups / program enrollments (web leads)

Telehealth consults booked

Supplement web purchases, revenue, and ROAS

Enrolled patients via hub / CRM match-back

Geo-holdout incremental enrollment lift

04

What did each outcome cost?

ACQUISITION EFFICIENCY-COST PER REAL RESULT

Cost per enrolled patient (via match-back)

Cost per telehealth consult

Cost per lead

Cost per unique household reached

Cost per completed view

CORE CONVICTIONS.

Brand Signals

  • Condition awareness lift

  • Aided and unaided brand awareness lift

  • Brand-condition association lift

  • Message recall lift

  • “Talk to your doctor” intent lift

Intent Signals

  • Branded and condition search lift

  • Doctor discussion guide engagement

  • Co-pay or savings-card engagement

  • Patient support program engagement

  • HCP-locator lift, where applicable

Business Outcomes

  • Incremental new prescriptions

  • Incremental patient starts

  • Refill or adherence lift

  • Therapy initiation lift

Acquisition Efficiency

  • Cost per qualified patient action

  • Cost per savings-card download

  • Cost per doctor discussion guide download

  • Cost per patient support enrollment

  • Cost per incremental NRx, where measurable

Home > Industry > Pharma DTC

Industry 03 · High Fit · Regulated

Pharma DTC

The pressure you're under:

Your media plan has to satisfy MLR review, FDA fair-balance requirements, brand-safety standards your legal team can defend, and a CFO who wants to see incremental script lift — not just impressions. Most agencies don't understand the regulatory layer, and the ones that do are charging you a premium for the privilege of compliance theater. Meanwhile, 58% of pharma marketers plan to increase CTV spend in 2026, and your team is being asked to scale into a channel without a partner who can navigate it cleanly.

Where CTV solves it:

CTV gives DTC pharma the brand-safe, premium-environment, household-precision targeting that linear can't and that social media won't risk. We work inside MLR-reviewed creative workflows, run HIPAA-aware audience targeting where the data partner allows, and stay inside premium streaming inventory — never on long-tail or open-exchange placements that introduce brand-safety exposure. Reporting is structured for compliance review, not just media review.

The KPIs we'll be accountable to:

Cost per branded search

Cost per HCP locator visit

Incremental Rx lift in test markets vs. holdout

Reach against verified in-market patient audiences

Brand favorability lift in adjacency-controlled studies

Built for the pharma DTC CMO whose media plan has to clear MLR, satisfy the CFO, and grow scripts in the same quarter — without inviting a brand-safety incident.